V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270020029 | 270009064 | 1.73 | 61.3 | null | null | 2019-07-11 | Rituximab | 2 | N | 270014959 | RITUXIMAB |
| 270020030 | 270009069 | 1.65 | 52.5 | Palliative (P) | 2018-06-05 | 2018-12-03 | Mini BEAM | 2 | N | 270014962 | BEAM |
| 270020031 | 270009116 | 1.85 | 130 | Adjuvant (A) | 2018-01-31 | 2018-03-04 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270015048 | NOT MATCHED |
| 270020032 | 270019159 | 1.54 | 59.2 | Palliative (P) | 2015-11-25 | 2015-12-15 | DHAP | 02 | N | 270015083 | DHAP |
| 270020033 | 270020254 | 1.63 | 55 | Palliative (P) | 2016-11-16 | 2016-11-22 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015099 | FLUOROURACIL |
| 270020034 | 270009140 | 1.82 | 66 | Adjuvant (A) | 2017-03-08 | 2018-02-22 | Capecitabine (21 day) + Irinotecan | 02 | N | 270015108 | CAPECITABINE + IRINOTECAN |
| 270020035 | 270019169 | 1.83 | 77.6 | Neo-adjuvant (N) | 2017-02-01 | 2017-03-13 | CAPECITABINE + RT | N | N | 270015246 | CAPECITABINE + RT |
| 270020036 | 270009215 | 1.7 | 112 | Palliative (P) | 2016-09-18 | 2016-10-04 | CHOP R - 21 days | N | N | 270015286 | CHOP R |
| 270020037 | 270009281 | 1.75 | 48.6 | null | 2016-11-24 | 2016-12-25 | Fluouracil continuous infusion | 02 | Y | 270015462 | FLUOROURACIL |
| 270020038 | 270009319 | 1.47 | 98 | null | 2018-08-10 | 2018-12-04 | DHAP | 02 | N | 270015528 | DHAP |
| 270020039 | 270014364 | 0 | 64 | Palliative (P) | 2016-02-06 | 2016-02-13 | CHLVPP | 02 | Y | 270015578 | CHLVPP |
| 270020040 | 270009404 | 1.98 | 87 | null | 2016-09-03 | 2016-09-03 | null | N | N | 270015795 | NOT MATCHED |
| 270020041 | 270014410 | 1.78 | 77.8 | Curative (C) | 2018-09-07 | 2018-09-25 | DHAP | N | N | 270015884 | DHAP |
| 270020043 | 270009469 | 1.74 | 72.3 | Adjuvant (A) | 2015-05-05 | 2016-06-14 | CHLVPP | 02 | N | 270015983 | CHLVPP |
| 270020044 | 270009492 | 1.55 | 72.4 | Curative (C) | 2018-03-03 | 2018-11-06 | CHLVPP | N | Y | 270016074 | CHLVPP |
| 270020045 | 270009540 | null | 95.6 | null | 2019-12-25 | 2020-04-28 | CHOP R | 02 | N | 270016250 | CHOP R |
| 270020046 | 270016969 | 1.76 | 64 | Curative (C) | 2015-04-24 | 2015-11-17 | CHOP R | 2 | N | 270016297 | CHOP R |
| 270020047 | 270014489 | 1.61 | 83.6 | Curative (C) | 2015-11-04 | 2015-11-22 | DHAP | null | null | 270016405 | DHAP |
| 270020048 | 270009629 | 1.62 | 87.5 | Neo-adjuvant (N) | 2015-06-16 | 2015-06-16 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016490 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270020049 | 270009651 | 1.64 | 52.7 | Curative (C) | 2019-08-15 | 2019-08-16 | Carboplatin AUC 6 - 10 | N | N | 270016559 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270020050 | 270009657 | 1.82 | 79.8 | Adjuvant (A) | 2018-08-30 | 2018-09-02 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | N | 270016596 | CISPLATIN + GEMCITABINE |
| 270020051 | 270014524 | 1.95 | 78.4 | Curative (C) | 2019-06-15 | 2019-08-14 | Panitumumab | null | N | 270016607 | VINBLASTINE |
| 270020052 | 270009670 | 1.89 | 81.2 | Curative (C) | 2018-10-16 | 2019-01-28 | NIVOLUMAB | 02 | N | 270016619 | GEMCITABINE |
| 270020053 | 270009677 | 1.65 | 89.4 | Palliative (P) | 2018-07-06 | 2018-08-30 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270016635 | GEMCITABINE |
| 270020054 | 270009687 | 1.77 | 49.1 | Disease modification (D) | 2016-07-31 | 2017-02-02 | Panitumumab | N | N | 270016660 | CETUXIMAB + OXALIPLATIN + MDG |
| 270020055 | 270017023 | 1.79 | 81.5 | Adjuvant (A) | 2016-08-01 | 2016-09-27 | BEAM + Alemtuzumab Allo SCT | 2 | N | 270016682 | VINBLASTINE |
| 270020056 | 270009724 | 1.5 | 37 | Adjuvant (A) | null | 2014-06-04 | GEMCITABINE | N | N | 270016761 | CETUXIMAB + OXALIPLATIN + MDG |
| 270020057 | 270009742 | null | 71.7 | Curative (C) | 2014-11-15 | 2014-11-18 | Bevacizumab | 02 | N | 270016783 | BEVACIZUMAB |
| 270020058 | 270014572 | 1.67 | 47 | Curative (C) | 2020-05-05 | 2020-05-06 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | 270016828 | BEAM + ALEMTUZUMAB |
| 270020059 | 270014577 | 1.61 | null | Curative (C) | 2016-03-11 | 2016-05-13 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 270016872 | IGEV |
| 270020060 | 270014583 | null | 37 | Curative (C) | 2017-09-18 | 2018-02-18 | IVE | N | N | 270016922 | IVE |
| 270020061 | 270009807 | 1.8 | 52 | Curative (C) | 2019-04-22 | 2019-04-23 | Cyclophosphamide High Dose | N | Y | 270016989 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270020062 | 270009821 | 1.7 | 74 | Curative (C) | 2015-01-03 | 2015-01-03 | Vinblastine | N | N | 270017016 | CETUXIMAB + OXALIPLATIN + MDG |
| 270020063 | 270014606 | 1.48 | 63 | Curative (C) | 2017-01-02 | 2017-01-08 | ABVD R | N | N | 270017056 | ABVD R |
| 270020064 | 270009850 | 1.71 | 77.4 | Curative (C) | 2019-07-21 | 2019-07-22 | AFLIBERCEPT + FU + IRINOTECAN | 02 | Y | 270017063 | CISPLATIN |
| 270020065 | 270009873 | 1.79 | null | Curative (C) | 2019-05-30 | 2019-06-12 | Cisplatin 7 day | 02 | N | 270017117 | BEVACIZUMAB |
| 270020066 | 270009905 | 1.67 | 78 | Adjuvant (A) | 2016-09-04 | 2016-09-05 | Vinblastine | 2 | N | 270017233 | PANITUMUMAB |
| 270020067 | 270009921 | 1.72 | 67.5 | Curative (C) | 2014-01-13 | 2014-01-15 | IGEV | 02 | null | 270017260 | ABVD R |
| 270020068 | 270009935 | 1.8 | 71.24 | Curative (C) | 2015-10-02 | 2015-12-29 | IGEV | 02 | N | 270017287 | AFLIBERCEPT + FU + IRINOTECAN |
| 270020069 | 270009939 | 1.77 | 79.4 | Adjuvant (A) | 2016-05-16 | 2016-11-08 | Oxaliplatin + Raltitrexed | 02 | N | 270017290 | OXALIPLATIN + RALTITREXED |
| 270020070 | 270009955 | 1.7 | null | Palliative (P) | 2017-10-06 | 2018-07-07 | Cyclophosphamide High Dose | 2 | N | 270017306 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270020071 | 270009966 | 1.36 | 29.2 | Curative (C) | 2016-05-20 | 2016-05-29 | Irinotecan | 2 | N | 270017328 | IRINOTECAN |
| 270020072 | 270014658 | 1.86 | 92.6 | Curative (C) | null | 2018-11-11 | Carboplatin+Fluorouracil 4 or 5 day | null | null | 270017330 | IRINOTECAN + MDG + PANITUMUMAB |
| 270020073 | 270009992 | 1.88 | 69.4 | null | 2017-04-22 | 2017-05-08 | Methotrexate intrathecal | N | N | 270017382 | GEMCITABINE + OXALIPLATIN |
| 270020074 | 270010009 | 1.73 | 68 | Disease modification (D) | 2017-05-20 | 2017-06-11 | CYCLOPHOSPHAMIDE + MESNA | null | null | 270017427 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270020075 | 270010017 | null | null | Palliative (P) | 2016-06-27 | 2016-07-21 | LOPP | N | null | 270017431 | RCEOP |
| 270020077 | 270010098 | null | null | Palliative (P) | 2019-11-05 | 2019-12-19 | CVP R | N | null | 270017792 | GEMCITABINE + OXALIPLATIN |
| 270020078 | 270014733 | 1.79 | 63.9 | Curative (C) | 2015-06-15 | 2015-06-16 | ETOPOSIDE | 2 | N | 270018171 | ETOPOSIDE |
| 270020079 | 270010141 | 1.56 | null | Palliative (P) | 2018-02-10 | 2018-04-08 | ICE | 02 | N | 270018255 | ESHAP R |
| 270020080 | 270010158 | null | 114 | Palliative (P) | null | 2018-05-03 | CVP R | null | N | 270018427 | CYTARABINE HIGH DOSE |